News

Filter

Current filters:

Regulation

201 to 210 of 95916 results

Pfizer agrees to pay $35 million for improper marketing of Rapamune

Pfizer agrees to pay $35 million for improper marketing of Rapamune

07-08-2014

US pharma giant Pfizer has reached a $35 million settlement with 41 states in the USA and the District…

LegalPfizerPharmaceuticalRapamuneUSA

Shares in Cytori fall as it announces suspension of heart disease trial

Shares in Cytori fall as it announces suspension of heart disease trial

07-08-2014

Shares in Cytori Therapeutics declined as much as 29% as it announced it was suspending enrollment in…

Cardio-vascularCytori TherapeuticsIschemic heart diseasePharmaceuticalResearchUSA

Novo Nordisk beats estimates as net profit grows 4%

Novo Nordisk beats estimates as net profit grows 4%

07-08-2014

Danish diabetes care giant Novo Nordisk released first-half 2014 financial results this morning, showing…

Business FinanceChief executiveDiabetesFinancialNOKNovo NordiskPeptide hormonesPharmaceuticalRecombinant proteins

Sanofi partners with Emcure for oncology portfolio in India

Sanofi partners with Emcure for oncology portfolio in India

06-08-2014

French pharma major Sanofi’s Indian subsidiary said today that it has entered into a marketing and…

Emcure PharmaceuticalsFasturtecFludaraIndiaJevtanaMarkets & MarketingOncologyPharmaceuticalSanofiTaxotere

Cubist Pharmaceuticals voluntarily recalls Cubicin lots in the USA

Cubist Pharmaceuticals voluntarily recalls Cubicin lots in the USA

06-08-2014

American biopharmaceutical company Cubist has issued a voluntary recall of certain lots of Cubicin (daptomycin…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsPhlebitisRegulationThromboembolismUSA

Walgreens to buy remainder of Boots Alliance, but shuns inversion

06-08-2014

US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

PatientsLikeMe and Actelion to collaborate on new tool for non-Hodgkin’s lymphoma patients

PatientsLikeMe and Actelion to collaborate on new tool for non-Hodgkin’s lymphoma patients

06-08-2014

Swiss biotech firm Actelion is to partner with patient-powered research network PatientsLikeMe to create…

ActelionMitchell NagaoOncologyPatientsLikeMePharmaceuticalResearchSwitzerland

201 to 210 of 95916 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top